查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
中空纖維過濾的市場規模，佔有率，趨勢分析:各材料，各技術，各用途，各終端用戶，各地區展望，競爭策略，至2030年的各市場區隔預測
市場調查報告書
商品編碼
1070365

中空纖維過濾的市場規模，佔有率，趨勢分析:各材料，各技術，各用途，各終端用戶，各地區展望，競爭策略，至2030年的各市場區隔預測

Hollow Fiber Filtration Market Size, Share & Trends Analysis By Material, By Technique, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 213 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球中空纖維過濾的市場規模，預計今後以11.2％的年複合成長率擴大，至2030年達到7億9,670萬美元。感染疾病的流行和對健康的意識高漲，影響對疫苗和單株抗體，個人化醫療的細胞培養的引進。

本報告提供全球中空纖維過濾市場相關調查，市場概要，以及各材料，各技術，各用途，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 成長要素，阻礙因素，機會，課題的分析
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • COVID-19中空纖維過濾市場的影響

第5章 市場變數及預測

  • SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • PESTEL分析
    • 政治形勢
    • 經濟形勢
    • 社會形勢
    • 技術形勢
    • 環境形勢
    • 法律上的形勢
  • 波特的五力分析
    • 賣主談判力
    • 買方議價能力
    • 替代威脅
    • 新加入廠商的威脅
    • 競爭企業間的敵對關係
  • 熱圖分析

第6章 中空纖維過濾市場，各材料，2019年～2030年(100萬美元)

  • 陶瓷
  • 其他的高分子材料
  • 高分子
  • 聚二氟亞乙烯(PVDF)
  • PS/PES

第7章 中空纖維過濾市場，各技術，2019年～2030年(100萬美元)

  • 微過濾
    • 不滿0.2微米
    • 0.2～0.7微米
  • 超過濾
    • 50,000 kDa以上
    • 10,000kDa～50,000kDa
    • 不滿10,000 kDa

第8章 中空纖維過濾市場，各用途，2019年～2030年(100萬美元)

  • 連續細胞灌流
  • 收穫和清澄化
  • 濃縮和血液透析機過濾

第9章 中空纖維過濾市場，各終端用戶，2019年～2030年(100萬美元)

  • 製藥公司，生物科技廠商
  • CRO，CMO
  • 其他

第10章 中空纖維過濾市場，各地區，2019年～2030年(100萬美元)

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 中東、非洲
    • 沙烏地阿拉伯王國
    • 阿拉伯聯合大公國
    • 其他

第11章 企業簡介

  • Alpha Plan GmbH
  • Antylia Scientific
  • APAH technologies
  • Asahi Kasei Corporation
  • Biotree
  • BiOZEEN Pvt. Ltd.
  • Cantel Medical
  • CoorsTek, Inc.
  • Danaher
  • Koch Industries Inc.
  • Kuraray Co., Ltd.
  • MANN+HUMMEL Holding GmbH
  • Meissner Filtration Product, Inc
  • Parker-Hannifin Corp
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • TOYOBO CO., LTD
簡介目錄
Product Code: BIOT2215

Global Hollow Fiber Filtration Market projected to be worth USD 796.7 million by 2030.

According to SPER Market Research, the Hollow Fiber Filtration Market estimated to reach USD 796.7 million by 2030 with a CAGR of 11.2%. Growing exploit of single use technologies, increasing biopharmaceutical industries, rising inclination towards continuous manufacturing; are the key factors which act as the fuel for the escalation of the market.

Impact of COVID-19 on the Hollow Fiber Filtration Market

The outbreak of COVID-19 has boosted the research for the treatment and vaccine manufacture, with the hollow fiber filtration by the pharmaceutical, biopharmaceutical companies, and the players of the Hollow fiber filtration market to target the corona virus infection. Thus COVID-19 has a positive impact on this market.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered By Material, By Technique, By Application, By End-Users, By Region

  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • Companies Covered: Alpha Plan GmbH, Alpha Plan GmbH, Antylia Scientific, APAH technologies, Asahi Kasei Corporation, Biotree, BiOZEEN Pvt. Ltd., Cantel Medical, CoorsTek, Inc., Danaher, Koch Industries Inc., Kuraray Co., Ltd., MANN+HUMMEL Holding GmbH, Meissner Filtration Product, Inc, MMS Membrane System, Parker-Hannifin Corp, Repligen Corporation, Sartorius Stedim Biotech S.A, TOYOBO CO., LTD.

Driver: expansion in the biopharmaceutical industry

Growing usage of single-use technologies, increase in the biopharmaceutical industry, growing preference for continuous manufacturing; are the key factors for the expansion of the market.

Opportunity: Emerging economies

In Emerging economies, there is rising government support and private investments, demand for single used technology, increasing biosimilars, increasing investments in cell-based research, this growth in biopharmaceuticals is going to offer enormous opportunities for the players in the Hollow Fiber Filtration Market.

Challenges: Membrane fouling and fiber breakage

The main problems regarding hollow fiber filtration are; permanent fouling and fiber breakage, moderate capital costs, high operating costs. These are the challenges to the market.

Hollow Fiber Filtration Market, By Material:

Based on the Material, Hollow Fiber Filtration Market is segmented as; Ceramic, Polymeric, Polyvinylidene fluoride (PVDF), PS/PES, Other polymeric materials.

Hollow Fiber Filtration Market, By Technique:

Based on the Technique, Hollow Fiber Filtration Market is segmented as; Microfiltration (<0.2 Micron Meter, >0.2 Micron Meter and <0.7 Micron Meter), Ultrafiltration (>50,000 kDa, >10,000 kDa and <50,000 kDa, <10,000 kDa).

Hollow Fiber Filtration Market, By Application:

Based on the Application, Hollow Fiber Filtration Market is segmented as; Continuous Cell Perfusion, Harvest and Clarification, Concentration and Diafiltration.

Hollow Fiber Filtration Market, By End User:

Based on the End-Users, Hollow Fiber Filtration Market is segmented as; Pharmaceutical and Biotechnology Manufacturers, Contract Research Organization and Contract Manufacturing Organization (CROs & CMOs), other end users.

Hollow Fiber Filtration Market, By Region:

North America owns the prime share of this market; this is due to the focus of companies on new products such as perfusion systems, ease, and cost-efficiency of hollow fiber filters and the growing demand for filtration systems for the biopharmaceuticals industry.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Hollow Fiber Filtration Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Hollow Fiber Filtration Market, By Material, 2019-2030 (USD Million)

  • 6.1. Ceramic
  • 6.2. Other polymeric materials
  • 6.3. Polymeric
  • 6.4. Polyvinylidene fluoride (PVDF)
  • 6.5. PS/PES

7. Hollow Fiber Filtration Market, By Technique, 2019-2030 (USD Million)

  • 7.1. Microfiltration
    • 7.1.1. <0.2 Micron Meter
    • 7.1.2. >0.2 Micron Meter and <0.7 Micron Meter
  • 7.2. Ultrafiltration
    • 7.2.1. >50,000 kDa
    • 7.2.2. >10,000 kDa and <50,000 kDa
    • 7.2.3. <10,000 kDa

8. Hollow Fiber Filtration Market, By Application, 2019-2030 (USD Million)

  • 8.1. Continuous Cell Perfusion
  • 8.2. Harvest and Clarification
  • 8.3. Concentration and Diafiltration

9. Hollow Fiber Filtration Market, By End User, 2019-2030 (USD Million)

  • 9.1. Pharmaceutical and Biotechnology Manufacturers
  • 9.2. Contract Research Organization and Contract Manufacturing Organization (CROs & CMOs)
  • 9.3. Other end users

10. Hollow Fiber Filtration Market, By Region, 2019-2030 (USD Million)

  • 10.1. North America
    • 10.1.1. United States
    • 10.1.2. Canada
    • 10.1.3. Mexico
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. United Kingdom
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. South Korea
    • 10.3.6. Rest of Asia-Pacific
  • 10.4. South America
    • 10.4.1. Brazil
    • 10.4.2. Argentina
    • 10.4.3. Rest of South America
  • 10.5. Middle East & Africa
    • 10.5.1. Kingdom of Saudi Arabia
    • 10.5.2. United Arab Emirates
    • 10.5.3. Rest of Middle East & Africa

11. Company Profiles

  • 11.1. Alpha Plan GmbH
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary
    • 11.1.4. Recent developments
  • 11.2. Antylia Scientific
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary
    • 11.2.4. Recent developments
  • 11.3. APAH technologies
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary
    • 11.3.4. Recent developments
  • 11.4. Asahi Kasei Corporation
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary
    • 11.4.4. Recent developments
  • 11.5. Biotree
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary
    • 11.5.4. Recent developments
  • 11.6. BiOZEEN Pvt. Ltd.
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary
    • 11.6.4. Recent developments
  • 11.7. Cantel Medical
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary
    • 11.7.4. Recent developments
  • 11.8. CoorsTek, Inc.
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary
    • 11.8.4. Recent developments
  • 11.9. Danaher
    • 11.9.1. Company details
    • 11.9.2. Financial outlook
    • 11.9.3. Product summary
    • 11.9.4. Recent developments
  • 11.10. Koch Industries Inc.
    • 11.10.1. Company details
    • 11.10.2. Financial outlook
    • 11.10.3. Product summary
    • 11.10.4. Recent developments
  • 11.11. Kuraray Co., Ltd.
    • 11.11.1. Company details
    • 11.11.2. Financial outlook
    • 11.11.3. Product summary
    • 11.11.4. Recent developments
  • 11.12. MANN+HUMMEL Holding GmbH
    • 11.12.1. Company details
    • 11.12.2. Financial outlook
    • 11.12.3. Product summary
    • 11.12.4. Recent developments
  • 11.13. Meissner Filtration Product, Inc
    • 11.13.1. Company details
    • 11.13.2. Financial outlook
    • 11.13.3. Product summary
    • 11.13.4. Recent developments
  • 11.14. Parker-Hannifin Corp
    • 11.14.1. Company details
    • 11.14.2. Financial outlook
    • 11.14.3. Product summary
    • 11.14.4. Recent developments
  • 11.15. Repligen Corporation
    • 11.15.1. Company details
    • 11.15.2. Financial outlook
    • 11.15.3. Product summary
    • 11.15.4. Recent developments
  • 11.16. Sartorius Stedim Biotech S.A
    • 11.16.1. Company details
    • 11.16.2. Financial outlook
    • 11.16.3. Product summary
    • 11.16.4. Recent developments
  • 11.17. TOYOBO CO., LTD
    • 11.17.1 Company details
    • 11.17.2 Financial outlook
    • 11.17.3 Product summary
    • 11.17.4 Recent developments